US Patent No: 7,713,297

Number of patents in Portfolio can not be more than 2000

Drug-releasing stent with ceramic-containing layer

ALSO PUBLISHED AS: 20040039438
1 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A vascular or endoluminal stent is adapted to be implanted in a vessel, duct or tract of a human body to maintain an open lumen at the site of the implant. The sidewall of the open-ended tubular structure of the stent is a base layer of a metal biologically compatible with blood and tissue of the human body. An intermediate metal particle layer of substantial greater radiopacity overlies the base layer, with particles bonded to the base layer and to each other to leave interstices therebetween as a repository for retaining and dispensing drugs or other agents for time release therefrom after the stent is implanted, to assist the stent in maintaining the lumen open. The particles are composed primarily of a noble metal—an alloy of platinum-iridium. The sidewall has holes extending therethrough, and the particle layer resides along the outward facing and inward facing surfaces, and the edges of the through holes and open ends of the sidewall. The larger particles are bonded to surfaces of the sidewall and progressively smaller particles are bonded to those and to each other up to the outer portion of the particle layer. Exposed surfaces of the particle layer are coated with ceramic-like iridium oxide or titanium nitrate, as a biocompatible material to inhibit irritation of tissue at the inner lining of the vessel when the stent is implanted. One or more anti-thrombotic, anti-platelet, anti-inflammatory and/or anti-proliferative drugs are retained in the interstices, together with a biodegradable carrier for time release therefrom. In an alternative embodiment, the intermediate layer is solid and the biodegradable carrier and drugs or agents therein are applied to the surface of the ceramic-like coating. Gene transfer is alternatively used to control tissue proliferation.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
BOSTON SCIENTIFIC SCIMED, INC.MAPLE GROVE, MN4875

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alt, Eckhard Ottobrunn, DE 134 6101

Cited Art Landscape

Patent Info (Count) # Cites Year
 
BOSTON SCIENTIFIC SCIMED, INC. (10)
5,195,969 Co-extruded medical balloons and catheter using such balloons 284 1991
5,270,086 Multilayer extrusion of angioplasty balloons 377 1991
5,304,121 Drug delivery system making use of a hydrogel polymer coating 504 1991
5,366,504 Tubular medical prosthesis 440 1992
5,674,192 Drug delivery 210 1993
5,397,307 Drug delivery PTCA catheter and method for drug delivery 159 1993
5,449,382 Minimally invasive bioactivated endoprosthesis for vessel repair 365 1994
5,439,446 Stent and therapeutic delivery system 264 1994
5,578,075 Minimally invasive bioactivated endoprosthesis for vessel repair 254 1995
5,824,077 Clad composite stent 134 1995
 
MEDTRONIC, INC. (5)
4,886,062 Intravascular radially expandable stent and method of implant 1287 1987
5,607,463 Intravascular medical device 300 1993
5,443,496 Intravascular radially expandable stent 401 1993
5,591,224 Bioelastomeric stent 255 1994
5,624,411 Intravascular stent and method 522 1995
 
ADVANCED CARDIOVASCULAR SYSTEMS, INC. (3)
5,605,696 Drug loaded polymeric material and method of manufacture 615 1995
6,174,329 Protective coating for a stent with intermediate radiopaque coating 186 1996
5,843,172 Porous medicated stent 373 1997
 
SCIMED LIFE SYSTEMS, INC. (3)
5,464,450 Biodegradable drug delivery vascular stent 277 1994
5,551,954 Biodegradable drug delivery vascular stent 285 1994
5,500,013 Biodegradable drug delivery vascular stent 327 1995
 
AMS MEDINVENT S.A. (2)
4,655,771 Prosthesis comprising an expansible or contractile tubular body 1335 1983
5,061,275 Self-expanding prosthesis 634 1989
 
CORDIS CORPORATION (2)
4,994,071 Bifurcating stent apparatus and method 927 1989
5,163,958 Carbon coated tubular endoprosthesis 400 1991
 
LIFESHIELD SCIENCES LLC (2)
4,657,544 Cardiovascular graft and method of forming same 98 1984
5,693,085 Stent with collagen 486 1995
 
MED INSTITUTE, INC. (2)
5,609,629 Coated implantable medical device 659 1995
5,873,904 Silver implantable medical device 754 1997
 
ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH (1)
5,405,367 Structure and method of manufacture of an implantable microstimulator 314 1993
 
Battelle-Institut e.V. (1)
4,202,055 Anchorage for highly stressed endoprostheses 113 1977
 
BOSTON SCIENTIFIC CORPORATION (1)
5,843,089 Stent lining 151 1996
 
BRIDGE BLOOD TECHNOLOGIES LLC, NEW YORK LIMITED LIABILITY COMPANY (1)
5,322,520 Iontophoretic structure for medical devices 175 1992
 
COCHLEAR LIMITED (1)
5,279,292 Charging system for implantable hearing aids and tinnitus maskers 215 1992
 
COOK INCORPORATED (1)
4,800,882 Endovascular stent and delivery system 1253 1987
 
DAI NIPPON PRINTING CO., LTD. (1)
5,679,440 Optical card 47 1995
 
DUKE UNIVERSITY (1)
5,527,337 Bioabsorbable stent and method of making the same 392 1994
 
EXPANDABLE GRAFTS PARTNERSHIP, 8000 I.H. 10 WEST, STE. 1265, SAN ANTONIO, TX A GENERAL PARTNERSHIP OF TX. (1)
4,733,665 Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft 2204 1985
 
GENE-TRAK SYSTEMS CORPORATION (1)
5,073,365 Clinical and personal care articles enhanced by lubricants and adjuvants 79 1989
 
GENERAL ELECTRIC COMPANY (1)
4,237,559 Bone implant embodying a composite high and low density fired ceramic construction 75 1979
 
INTEGRATED DEVICE TECHNOLOGY, INC. (1)
5,672,242 High selectivity nitride to oxide etch process 40 1996
 
INTERMEDICAT GMBH, GERLISWILSTRASSE 74, CH-6020 EMMENBRUCKE, SWITZERLAND, (1)
4,784,659 Vessel and prosthesis impregnated with diisocyanate crosslinked gelatin 89 1987
 
INTERNATIONAL BUSINESS MACHINES CORPORATION (1)
5,693,928 Method for producing a diffusion barrier and polymeric article having a diffusion barrier 44 1996
 
LATHAM, DANIEL W. (1)
5,464,650 Intravascular stent and method 776 1993
 
Lathrotec, Inc. (1)
5,120,322 Method and apparatus for treatment of fibrotic lesions 158 1990
 
MEDINOL LTD. (1)
5,449,373 Articulated stent 678 1994
 
MEDTRONIC AVE, INC. (1)
5,290,585 Lubricious hydrogel coatings 125 1992
 
PETER RICHTER (1)
5,302,414 Gas-dynamic spraying method for applying a coating 245 1992
 
Quanam Medical Corporation (1)
5,674,242 Endoprosthetic device with therapeutic compound 380 1996
 
REGENTS OF THE UNIVERSITY OF MINNESOTA (1)
4,585,652 Electrochemical controlled release drug delivery system 182 1984
 
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (1)
5,587,507 Synthesis of tyrosine derived diphenol monomers 100 1995
 
SCICO TEC GMBH (1)
5,102,403 Therapeutic medical instrument for insertion into body 152 1990
 
Shepherd Patents S.A. (1)
4,954,126 Prosthesis comprising an expansible or contractile tubular body 698 1989
 
SHIRKHANZADEH, MORTEZA (1)
5,205,921 Method for depositing bioactive coatings on conductive substrates 107 1991
 
SMITH & NEPHEW RICHARDS INC. (1)
5,649,951 Zirconium oxide and zirconium nitride coated stents 130 1995
 
SPINAL CORD SOCIETY A MN CORPORATION (1)
5,314,453 Position sensitive power transfer antenna 193 1991
 
SPIRE CORPORATION (1)
5,474,797 Bactericidal coatings for implants 90 1994
 
STENT TECH, INC. (1)
5,858,556 Multilayer composite tubular structure and method of making 261 1997
 
TDK CORPORATION (1)
5,125,971 Living hard tissue replacement, its preparation 78 1990
 
TECHNICAL SERVICES AND MARKETING, INC. (1)
5,603,556 Rail car load sensor 56 1995
 
The Kendall Company (1)
4,705,502 Suprapubic catheter with dual balloons 119 1986
 
The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (1)
4,308,868 Implantable electrical device 74 1980
 
The United States of America as represented by the Secretary of the Navy (1)
5,380,298 Medical device with infection preventing feature 70 1993
 
TINI ALLOY COMPANY (1)
5,061,914 Shape-memory alloy micro-actuator 312 1989
 
Travenol Laboratories (Israel) Ltd. (1)
4,976,692 Catheter particularly useful for inducing labor and/or for the application of a pharmaceutical substance to the cervix of the uterus 110 1989
 
ULVAC JAPAN, LTD., (1)
4,401,546 Ferromagnetic high speed sputtering apparatus 57 1982
 
UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (1)
5,091,205 Hydrophilic lubricious coatings 311 1989
 
UNIVERSITY OF UTAH (1)
4,334,327 Ureteral prosthesis 104 1979
 
WORLD HEART CORPORATION (1)
4,665,896 Power supply for body implant and method of use 133 1985
 
Other [Check patent profile for assignment information] (5)
5,236,413 Method and apparatus for inducing the permeation of medication into internal tissue 246 1990
5,147,370 Nitinol stent for hollow body conduits 493 1991
5,348,553 Method for promoting blood vessel healing 65 1991
5,383,935 Prosthetic implant with self-generated current for early fixation in skeletal bone 67 1993
5,690,670 Stents of enhanced biocompatibility and hemocompatibility 134 1995

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
BOSTON SCIENTIFIC SCIMED, INC. (38)
8,089,029 Bioabsorbable metal medical device and method of manufacture 1 2006
8,187,620 Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents 1 2006
8,048,150 Endoprosthesis having a fiber meshwork disposed thereon 1 2006
8,067,054 Stents with ceramic drug reservoir layer and methods of making and using the same 2 2007
7,976,915 Endoprosthesis with select ceramic morphology 1 2007
8,771,343 Medical devices with selective titanium oxide coatings 0 2007
8,002,823 Endoprosthesis coating 1 2007
7,942,926 Endoprosthesis coating 1 2007
7,931,683 Articles having ceramic coated surfaces 13 2007
8,052,743 Endoprosthesis with three-dimensional disintegration control 0 2007
8,353,949 Medical devices with drug-eluting coating 1 2007
8,052,744 Medical devices and methods of making the same 2 2007
8,052,745 Endoprosthesis 0 2007
8,002,821 Bioerodible metallic ENDOPROSTHESES 3 2007
8,128,689 Bioerodible endoprosthesis with biostable inorganic layers 1 2007
8,057,534 Bioerodible endoprostheses and methods of making the same 6 2007
7,955,382 Endoprosthesis with adjustable surface features 9 2007
7,981,150 Endoprosthesis with coatings 6 2007
8,216,632 Endoprosthesis coating 0 2007
8,029,554 Stent with embedded material 3 2007
7,938,855 Deformable underlayer for stent 2 2007
8,080,055 Bioerodible endoprostheses and methods of making the same 0 2007
8,431,149 Coated medical devices for abluminal drug delivery 0 2008
8,070,797 Medical device with a porous surface for delivery of a therapeutic agent 3 2008
7,998,192 Endoprostheses 2 2008
8,236,046 Bioerodible endoprosthesis 0 2008
8,221,822 Medical device coating by laser cladding 0 2008
7,985,252 Bioerodible endoprosthesis 3 2008
8,382,824 Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides 0 2008
8,071,156 Endoprostheses 1 2009
8,287,937 Endoprosthese 1 2009
8,449,603 Endoprosthesis coating 1 2009
8,231,980 Medical implants including iridium oxide 0 2009
8,267,992 Self-buffering medical implants 0 2010
8,066,763 Drug-releasing stent with ceramic-containing layer 0 2010
8,574,615 Medical devices having nanoporous coatings for controlled therapeutic agent delivery 0 2010
8,668,732 Surface treated bioerodible metal endoprostheses 0 2011
8,715,339 Bioerodible endoprostheses and methods of making the same 0 2011
 
REMON MEDICAL TECHNOLOGIES LTD. (1)
8,303,643 Method and device for electrochemical formation of therapeutic species in vivo 0 2010
 
Other [Check patent profile for assignment information] (1)
8,808,726 Bioerodible endoprostheses and methods of making the same 0 2007

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 11, 2017
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 11, 2021
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00